These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Neuroleptic malignant syndrome versus malignant hyperthermia. Hard C Am J Med; 1991 Sep; 91(3):322-3. PubMed ID: 1892158 [No Abstract] [Full Text] [Related]
26. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis. Kaufman KR; Levitt MJ; Schiltz JF; Sunderram J Ann Clin Psychiatry; 2006; 18(3):201-4. PubMed ID: 16923659 [TBL] [Abstract][Full Text] [Related]
27. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy. Hashim H; Zeb-un-Nisa ; Alrukn SA; Al Madani AA J Pak Med Assoc; 2014 Apr; 64(4):471-3. PubMed ID: 24864649 [TBL] [Abstract][Full Text] [Related]
28. Acute Presentation of Nonmotor Symptoms in Parkinson's Disease. Kwei K; Frucht S Int Rev Neurobiol; 2017; 134():973-986. PubMed ID: 28805591 [TBL] [Abstract][Full Text] [Related]
31. Hyperthermia caused by drug interactions and adverse reactions. Paden MS; Franjic L; Halcomb SE Emerg Med Clin North Am; 2013 Nov; 31(4):1035-44. PubMed ID: 24176477 [TBL] [Abstract][Full Text] [Related]
32. Malignant syndromes: current advances. Tao M; Li J; Wang X; Tian X Expert Opin Drug Saf; 2021 Sep; 20(9):1075-1085. PubMed ID: 33866917 [No Abstract] [Full Text] [Related]
33. A hazardous side effect of neuroleptics: diagnosis and treatment. Epperly TD; McGlaughlin VG; Leo KU Geriatrics; 1990 Aug; 45(8):58-62. PubMed ID: 1974232 [TBL] [Abstract][Full Text] [Related]
35. Neuroleptic malignant syndrome due to olanzapine. Hall KL; Taylor WH; Ware MR Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878 [TBL] [Abstract][Full Text] [Related]